The therapeutic community is excited with anticipation surrounding retatrutide, a novel dual GIP and GLP-1 receptor that’s demonstrating significant promise in clinical trials for managing obesity. Unlike some existing weight loss solutions, retatrutide appears to deliver a significant substantial reduction in body size and improve metabolic hea… Read More